Chevron Left
Zurück zu Medikamentenentwicklung

Bewertung und Feedback des Lernenden für Medikamentenentwicklung von University of California San Diego

4.7
Sterne
2,079 Bewertungen

Über den Kurs

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

Top-Bewertungen

HG

15. Okt. 2018

Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.

KR

24. Mai 2020

I am really glad to have course offered by california university . Its really helpful for me. And i am thankful to all lecturer, and teachers to explain overall drug development process.

Thank you!

Filtern nach:

301 - 325 von 415 Bewertungen für Medikamentenentwicklung

von Subramanian K

2. Sep. 2017

von Elena B

21. Apr. 2018

von Divya G

12. Juni 2021

von Dr. V A

29. Apr. 2021

von Suda J

1. Aug. 2020

von Savind C

2. Juni 2021

von Mary S

14. Juli 2020

von suzana

8. Nov. 2020

von Urjita J

1. Juni 2020

von Hussein S

14. Nov. 2017

von Sebastian F

24. Jan. 2021

von Muhamed S E

13. Aug. 2017

von yousef e

28. Sep. 2019

von Karen O

30. Juni 2020

von Jahnavi

13. Okt. 2020

von Álvaro S V

7. März 2019

von belmir a

26. Juli 2022

von Miguel M

26. Mai 2022

von Komal S

6. Juni 2020

von Murali D

9. Juli 2020

von Muhamad A B A B

8. Juli 2020

von Sanjida R M

15. März 2021

von IRINA B B G

30. Juli 2019

von Claudia S

3. Okt. 2021

von B M T I

4. Juni 2020